Trial Profile
Supplementation with alpha lipoic acid and hormone therapy with tibolone in menopausal transition: impact on oxidative stress, bone mass and quality of life.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Thioctic acid (Primary) ; Tibolone (Primary)
- Indications Menopausal syndrome
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 01 Mar 2011 New trial record